← Back to Search

Organic, Unrefined Coconut Oil for Contact Dermatitis

N/A
Waitlist Available
Research Sponsored by Genesis Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up once, at hospital discharge, an average of 2 weeks
Awards & highlights
No Placebo-Only Group

Summary

The purpose of the study is to examine the safety and effectiveness of the use of coconut oil for the prevention and treatment of diaper dermatitis among NICU babies at Genesis Medical Center, Davenport.

Eligible Conditions
  • Contact Dermatitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~once, at hospital discharge, an average of 2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and once, at hospital discharge, an average of 2 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The Number of Days Free From Diaper Dermatitis
The Number of Patients Experiencing Adverse Events
Secondary study objectives
The Percent of Parents Stating Satisfaction With the Diaper Dermatitis Treatment Used

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Coconut OilExperimental Treatment1 Intervention
Participants in this group will receive a generous layer of organic, unrefined coconut oil applied to the diaper area (buttocks and creases between thighs and hips) at each diaper change. This will continue until the patient is discharged or reaches the primary safety endpoint (skin that is eroded and/or blistered in the diaper area with bleeding).
Group II: Standard of CareActive Control1 Intervention
Participants in this group will receive the standard of care for preventing and treating diaper dermatitis at Genesis. This includes no treatment until a diaper dermatitis appears. If diaper dermatitis appears, participants will receive a generous layer of Medline Remedy Phytoplex Z-Guard Skin Protectant applied to the diaper area (buttocks and creases between thighs and hips) at each diaper change. This will continue until the patient is discharged or reaches the primary safety endpoint (skin that is eroded and/or blistered in the diaper area with bleeding).

Find a Location

Who is running the clinical trial?

Genesis Health SystemLead Sponsor
1 Previous Clinical Trials
71 Total Patients Enrolled
~15 spots leftby Nov 2025